The GLP is committed to full transparency. Download and review our 2019 Annual Report

British biotech company focuses on creating cellular factories

| January 31, 2014
bacteria
Image: Flickr/BrightonPiers, via Independent
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Synthace is the first company in the UK to specialise solely in the synthesis of new biological production systems, overseeing design all the way through to application. A spin-off from UCL, Synthace uses the university’s biochemical engineering facilities to test its innovative biological inventions that have applications for a range of industries.

The UK’s innovation agency has taken notice. In March 2013, the Technology Strategy Board awarded Synthace a £500,000 grant in collaboration with UCL and the University of Manchester for the “Rapid Engineering of Cellular Factories”. Using the suite of novel technologies at the firm’s disposal, the project’s ambitious aim is to tune cells that can convert abundant feedstocks such as vegetable oil into high value chemicals such as pigments, fragrances and pharmaceutical ingredients.

These new cellular factories not only promise to cut the cost and time normally associated with chemical production, but also waste, risk and energy use.

Read the full, original article: From bacterial robots to synthetic blood cells: The biotech boom at British universities

Additional Resources:

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend